Cosmos Health Secures Saudi Distribution Deal With 126K-Unit Initial Order
COSM sits 29% above its 52-week low of $0.162 on light trading volume (0.1× avg).
Summary
Cosmos Health signed an exclusive five-year distribution agreement with Innova Healthcare, one of Saudi Arabia's largest pharmacy networks, for its Sky Premium Life supplements. The deal includes an immediate purchase order of 126,000 units and projects over 5 million units over the initial term. Innova operates 250+ pharmacies and is backed by Alkhabeer Capital, Tamer Group, and Cigalah Group. This expands Cosmos Health's Middle East footprint beyond the UAE and taps a Saudi nutraceuticals market estimated at $3.26 billion. The company's Q2 loss doubled to $6.09M with going concern doubts, so this revenue stream is a meaningful positive. Watch for product registration completion with Saudi authorities before commercial launch.
At the time of this announcement, COSM was trading at $0.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21M. The 52-week trading range was $0.16 to $1.32. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.